Remote & miniaturized tech
Medical wearable and insertable devices are designed to improve the monitoring and management of issues linked to chronic conditions like diabetes, heart failure, or arrythmia. Mobile-compatible continuous glucose monitors are readily available today. Data collected from such devices enable doctors to analyze blood glucose fluctuations effortlessly and accurately and change treatment plans accordingly.
Remotely managed devices can enable doctors to have by-the-minute reports on their patients from anywhere. This data can help during pre- and post-treatment observation periods, assessment of response to therapies, and predictability of previously unforeseen health events.
AI, ML help interpret health data intelligently
AI and ML can enhance the effectiveness of innovations like biosensors. Biosensors study the composition of body fluids to help monitor patient wellbeing and provide data for early detection, diagnosis, and treatment of chronic diseases. For instance, cardiac biosensors can detect specific biomarkers such as myoglobin, cardiac troponin, interleukins, and interferon to analyze heart health.
It supports medical practitioners in delivering a timely diagnosis and medical attention, helping save more lives. In 2019, Dr David Spindell, divisional vice president of medical and clinical affairs for Abbott's diagnostics business, spoke at the Wall Street Journal’s Tech Health conference in San Francisco. He said, “Using machine learning, we've found that in combination, patient demographics plus hematological measures and blood proteins are much more accurate in diagnosing heart attacks as well as heart disease than current methods.”
FOLLOW ABBOTT